Exhibit 10.32.6
FIFTH AMENDMENT TO
TERM LOAN AGREEMENT
THIS FIFTH AMENDMENT TO TERM LOAN AGREEMENT (this "Fifth
Amendment") is made and entered into as of March 20, 1998, by and between
GENZYME TRANSGENICS CORPORATION, a Massachusetts corporation having its
principal place of business at Xxx Xxxxxxxx Xxxx, Xxxxxxxxxx, Xxxxxxxxxxxxx
00000 (the "Borrower"), and THE FIRST NATIONAL BANK OF BOSTON (the "Bank"), a
national banking association with its head office at 000 Xxxxxxx Xxxxxx, Xxxxxx,
Xxxxxxxxxxxxx 00000.
WHEREAS, the Borrower and the Bank entered into a Term Loan Agreement
dated as of December 15, 1995, as amended by the First Amendment to Term Loan
Agreement dated as of March 29, 1996, the Second Amendment to Term Loan
Agreement dated as of October 1, 1996, the Third Amendment to Term Loan
Agreement dated as of February 21, 1997, and the Fourth Amendment to Term Loan
Agreement dated as of June 17, 1997 (as further amended and in effect from time
to time, the "Credit Agreement") pursuant to which the Bank extended credit to
the Borrower on the terms set forth therein;
WHEREAS, the Bank and the Borrower have agreed to amend
the Credit Agreement as hereinafter set forth;
NOW, THEREFORE, for good and valuable consideration the receipt and
sufficiency of which is hereby acknowledged, the parties hereto agree as
follows:
1. Definitions. Capitalized terms used herein
without definition have the meanings ascribed to them in the
Credit Agreement.
2. Amendment to Section 7.2(a) of the Credit Agreement. Section 7.2(a)
of the Credit Agreement is hereby amended by deleting the amount "$5,300,000"
which appears in clause (ix) of Section 7.2(a) and substituting in place thereof
the new amount "$7,250,000".
3. Amendment to Section 7.2(d) of the Credit Agreement. Section 7.2(d)
of the Credit Agreement is hereby deleted in its entirety and substituting in
place thereof the following:
"(d) the Borrower will not make, and will not permit
its Subsidiaries to make any distributions on or in respect of
its capital of any nature whatsoever, other than (i) dividends
payable solely in the
2
shares of common stock or distributions by any Subsidiary
of the Borrower to such Subsidiary's shareholders and (ii)
in the case of the Borrower, any penalty or redemption
payments due to the purchasers of the Borrower's Series A
Convertible Preferrred Stock, in an aggregate amount not to
exceed $2,000,000 during the term of this Agreement;
provided, however, that no Default or Event of Default will
exist or be continuing at the time of such payments or
after making such payments and the Borrower shall have
delivered to the Bank a compliance certificate evidencing
pro forma calculations with respect thereto;"
4. Amendment to Section 7.2(e) of the Credit Agreement.
Section 7.2(e) of the Credit Agreement is hereby amended by inserting
immediately after the phrase "Sale-Leaseback transaction" the following:
", except for those sale-leaseback transactions
associated with certain Indebtedness described in clause (ix)
of Section 7.2(a) herein."
5. Ratification, etc.
Except as expressly amended hereby, the Credit Agreement, the other
Loan Documents and all documents, instruments and agreements related thereto are
hereby ratified and confirmed in all respects and shall continue in full force
and effect. This Fifth Amendment and the Credit Agreement shall hereafter be
read and construed together as a single document, and all references in the
Credit Agreement or any related agreement or instrument to the Credit Agreement
shall hereafter refer to the Credit Agreement as amended by this Fifth
Amendment. By executing this Fifth Amendment where indicated below, the
Guarantor hereby ratifies and confirms its guaranty of the Obligations pursuant
to the terms of the Guaranty, as amended, and acknowledges and consents to the
terms of this Fifth Amendment.
6. GOVERNING LAW.
THIS FIFTH AMENDMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE
WITH THE LAWS OF THE COMMONWEALTH OF MASSACHUSETTS AND SHALL TAKE EFFECT AS A
SEALED INSTRUMENT IN ACCORDANCE WITH SUCH LAWS.
7. Counterparts. This Fifth Amendment may be executed in any number of
counterparts and by different parties hereto on separate counterparts, each of
which when so executed and delivered shall be an original, but all of which
counterparts taken together shall be deemed to constitute one and the same
instrument. A complete set of counterparts shall be lodged with the Bank.
3
8. Effectiveness. This Fifth Amendment shall become effective upon its
execution and delivery by the Borrower, the Guarantor and the Bank; provided,
however, the amendment set forth in Section 4 hereof shall be deemed to have
been effective as of December 30, 1996.
9. Entire Agreement. THE TERM LOAN AGREEMENT AS AMENDED REPRESENTS THE
FINAL AGREEMENT BETWEEN THE PARTIES AND MAY NOT BE CONTRADICTED BY EVIDENCE OF
PRIOR, CONTEMPORANEOUS, OR SUBSEQUENT ORAL AGREEMENTS OF THE PARTIES. THERE ARE
NO UNWRITTEN ORAL AGREEMENTS BETWEEN THE PARTIES.
[REMAINING PAGE INTENTIONALLY LEFT BLANK]
IN WITNESS WHEREOF, the undersigned have duly executed this Fifth
Amendment under seal as of the date first set forth above.
THE BORROWER:
GENZYME TRANSGENICS
CORPORATION
By: /s/ Xxxx X. Xxxxx
----------------------
Name: Xxxx X. Xxxxx
Title: Vice President
Address of the Borrower:
Xxx Xxxxxxxx Xxxx
Xxxxxxxxxx, XX 00000
Tel: (000) 000-0000
Fax: (000) 000-0000
THE BANK:
BANKBOSTON, N.A. (formerly
known as The First National
Bank of Boston)
By: /s/ Xxxxxx X. Xxxxxxx
---------------------------
Name: Xxxxxx X. Xxxxxxx
Title: Vice President
Address:
000 Xxxxxxx Xxxxxx
Xxxxxx, XX 00000
Tel: 000-000-0000
Fax: 000-000-0000
ACCEPTED AND AGREED
TO BY:
The Guarantor:
GENZYME CORPORATION
By: /s/ Xxxx X. Xxxxxx
------------------------
Name:
Title: Vice President, Treasurer
